CODXCo-Diagnostics, Inc.

Nasdaq codiagnostics.com


$ 1.34 $ 0.01 (0.37 %)    

Friday, 06-Sep-2024 15:59:50 EDT
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 1.34
$ 1.32 x 100
-- x --
-- - --
$ 0.98 - $ 2.23
277,925
na
42.76M
$ -1.57
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-14-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-16-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-24-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-14-2019 06-30-2019 10-Q
22 05-14-2019 03-31-2019 10-Q
23 04-01-2019 12-31-2018 10-K
24 11-14-2018 09-30-2018 10-Q
25 08-10-2018 06-30-2018 10-Q
26 05-14-2018 03-31-2018 10-Q
27 03-28-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-25-2017 06-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- Press Conference

Core News & Articles

- Reuters

 hc-wainwright--co-maintains-neutral-on-co-diagnostics-lowers-price-target-to-15

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target fr...

 co-diagnostics-q2-2024-gaap-eps-025-beats-034-estimate-sales-2656m-beat-375000k-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.34...

 co-diagnostics-expands-vector-control-customer-base-to-25-customers-across-15-us-states-following-an-installation-in-nevada-next-week

Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company with a unique, ...

 hc-wainwright--co-reiterates-neutral-on-co-diagnostics-maintains-2-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ:CODX) with a Neutral and maintains $2 price target.

 hc-wainwright--co-maintains-neutral-on-co-diagnostics-lowers-price-target-to-2

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target fr...

 co-diagnostics-q1-2024-gaap-eps-031-misses-021-estimate-sales-467854k-miss-3050m-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0....

 co-diagnostics-inc-appoints-richard-abbott-as-president-concurrent-with-the-co-naming-david-nielsen-to-be-its-chief-operations-officer

Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a unique, ...

 hc-wainwright--co-maintains-neutral-on-co-diagnostics-lowers-price-target-to-25

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target fr...

 co-diagnostics-q4-2023-gaap-eps-050-misses-020-estimate-sales-3555m-miss-3625m-estimate

Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION